ECILC.IS
Eczacıbaşı İlaç
Temel Analiz
Değerleme
- F/K34,20
- Forward F/K—
- PD/DD1,17
- EPS₺3,05
- Temettü Verimi%1,62Miktar: ₺1,75
Fiyat Aralığı
Trend
- Gün İçi₺63,95 — ₺65,20
- 50G Ortalama₺116,90Fiyat: −45,29%
- 200G Ortalama₺85,7617Fiyat: −25,43%
- Beta0,51Piyasadan daha stabil
Piyasa Verileri
Ölçek
- Piyasa Değeri71,47 Milyar ₺
- Günlük Hacim184 Milyon ₺
- Önceki Kapanış₺63,95
- Çalışan Sayısı1.071
Analist Tavsiyeleri
Görüşler
Şirket
Eczacıbaşı İlaç Hakkında
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment is involved in the production, marketing, and sale of medicines related to human health and veterinary medicines. The Real Estate Development segment engages in development of real estate properties; rental activities for serum facilities; and providing consulting services on land development and project management. The company was incorporated in 1951 and is based in Istanbul, Turkey. EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a subsidiary of Eczacibasi Holding A.S.
